User contributions for JDoerfler
24 October 2024
- 13:0713:07, 24 October 2024 diff hist +9 Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer No edit summary
- 13:0513:05, 24 October 2024 diff hist +7 Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer No edit summary
- 11:4111:41, 24 October 2024 diff hist −16 Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology No edit summary Tag: Manual revert
- 11:3911:39, 24 October 2024 diff hist +16 Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology No edit summary Tag: Reverted
- 09:4609:46, 24 October 2024 diff hist +1 Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization No edit summary
- 09:4509:45, 24 October 2024 diff hist +438 Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization No edit summary
- 09:4009:40, 24 October 2024 diff hist +17 Muecke et al. (2013): Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology-a subgroup analysis of a multicenter, phase III trial No edit summary
- 09:3809:38, 24 October 2024 diff hist +10 Muecke et al. (2013): Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology-a subgroup analysis of a multicenter, phase III trial No edit summary
- 09:3309:33, 24 October 2024 diff hist +335 Muecke et al. (2013): Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology-a subgroup analysis of a multicenter, phase III trial No edit summary
- 09:2909:29, 24 October 2024 diff hist +1 Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology No edit summary
- 09:2809:28, 24 October 2024 diff hist +78 Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology No edit summary
- 08:4408:44, 24 October 2024 diff hist +646 Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology No edit summary
- 08:2608:26, 24 October 2024 diff hist +675 Mix et al. (2015): Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck No edit summary
- 08:0508:05, 24 October 2024 diff hist +261 Mix et al. (2015): Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck No edit summary
18 October 2024
- 13:4913:49, 18 October 2024 diff hist +502 Laali et al. (2020): Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer No edit summary
- 13:3813:38, 18 October 2024 diff hist +574 Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 No edit summary
- 12:5512:55, 18 October 2024 diff hist +1 Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial No edit summary
- 12:5312:53, 18 October 2024 diff hist +562 Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial No edit summary
- 12:3612:36, 18 October 2024 diff hist +2 Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial No edit summary
- 12:3612:36, 18 October 2024 diff hist +315 Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial No edit summary
14 October 2024
- 14:0214:02, 14 October 2024 diff hist +585 Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients No edit summary
- 13:4313:43, 14 October 2024 diff hist +301 Stratton et al. (2010): Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer No edit summary
- 13:1313:13, 14 October 2024 diff hist +305 Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients No edit summary
- 13:0313:03, 14 October 2024 diff hist +12 Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients No edit summary
11 October 2024
- 13:1313:13, 11 October 2024 diff hist +1 Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer No edit summary
- 13:1313:13, 11 October 2024 diff hist +86 Hejazi et al. (2016): Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study No edit summary
- 13:1013:10, 11 October 2024 diff hist +85 Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer No edit summary
- 12:4912:49, 11 October 2024 diff hist +296 Ryan et al. (2013): Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients No edit summary
- 12:2512:25, 11 October 2024 diff hist +336 Rao et al. (2014): The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study No edit summary
- 12:0512:05, 11 October 2024 diff hist +612 Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer No edit summary
10 October 2024
- 08:3008:30, 10 October 2024 diff hist +437 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 08:2108:21, 10 October 2024 diff hist +519 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 08:1308:13, 10 October 2024 diff hist +368 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 07:5407:54, 10 October 2024 diff hist +71 Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme No edit summary
- 07:5107:51, 10 October 2024 diff hist +9 Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme No edit summary
- 07:4907:49, 10 October 2024 diff hist +16 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary
8 October 2024
- 14:2214:22, 8 October 2024 diff hist +17 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary
- 08:3108:31, 8 October 2024 diff hist −1 Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial No edit summary
1 October 2024
- 11:5811:58, 1 October 2024 diff hist +535 Strasser et al. (2006): Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…) No edit summary
- 08:3408:34, 1 October 2024 diff hist +444 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 07:5907:59, 1 October 2024 diff hist +917 Jatoi et al. (2002): Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study No edit summary
30 September 2024
- 12:4212:42, 30 September 2024 diff hist +13 Johnson et al. (2010): Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain No edit summary
- 12:4112:41, 30 September 2024 diff hist +4 Johnson et al. (2010): Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain No edit summary
- 12:4012:40, 30 September 2024 diff hist +1,036 Johnson et al. (2010): Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain No edit summary
- 09:3209:32, 30 September 2024 diff hist +198 Lichtmann et al. (2018): Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain No edit summary
- 09:2609:26, 30 September 2024 diff hist +508 Lichtmann et al. (2018): Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain No edit summary
27 September 2024
- 14:1814:18, 27 September 2024 diff hist +4 Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary
- 14:1514:15, 27 September 2024 diff hist +984 Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary
- 13:0213:02, 27 September 2024 diff hist +224 Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial No edit summary